Skip to main content
. 2019 Sep;16(9):706–709. doi: 10.11909/j.issn.1671-5411.2019.09.006

Table 2. Outcomes among patients based on anticoagulation use.

Outcome Warfarin (n = 160177) Dabigatran (n = 14968) Rivaroxaban (n = 11877) Apixaban (n = 9495)
Ischemic stroke 21619 (13.5%) 1663 (11.1%) 1427 (12.0%) 1331 (14.0%)
Hemorrhagic stroke 1875 (1.2%) 88 (0.6%) 88 (0.7%) 79 (0.8%)

Data are presented as n (%).